Drug Target Review

DECEMBER 9, 2024

The 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis and John Jumper from Google DeepMind for developing AlphaFold2, and to David Baker from the University of Washington for his work in computational protein design. These innovations have revolutionised the understanding of protein structures using artificial intelligence. Before AlphaFold, determining 3D protein structures was complex and time-consuming, and often required the use of experimental methods like X-ray crystallography an

Engineering 105

Engineering International Drug Development Science 105

Science Daily: Pharmacology News

DECEMBER 11, 2024

Researchers show that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older.

Disease 306

Disease Research 306

Drug Patent Watch

DECEMBER 11, 2024

The biopharmaceutical industry has witnessed a significant surge in the number of therapeutic molecules in development, leading to a corresponding increase in the number of contract development and manufacturing organizations (CDMOs). This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceuticals Compliance Drug Development 94

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- Beans, peas and lentils take center stage in newly proposed changes to dietary guidelines for Americans. In a report released this week by an advisory committee to the Agriculture Department, experts suggest that the.

246

246

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Collaborative Drug

DECEMBER 13, 2024

Vault Snack #27 - Hazard Codes

245

245

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. But what exactly is pharmacognosy, and how does it relate to the complex world of drug patents?

Drugs 89

Drugs Drug Development Pharmaceuticals Production 89

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- The ancient Japanese practice of reiki "energy healing" might help some cancer patients deal with the pain that can come with infusion therapies, new research shows. "Outpatients receiving reiki during infusion reported.

Treatment 246

Treatment Therapies Research 246

Collaborative Drug

DECEMBER 13, 2024

Vault Snack #26 - Using Saved Searches to Automate Screening

239

239

Science Daily: Pharmacology News

DECEMBER 13, 2024

A new study points to why, and how, Io became the most volcanic body in the solar system.

300

300

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Patent Watch

DECEMBER 10, 2024

Patents play a crucial role in protecting intellectual property and fostering innovation. However, the increasing complexity of patent systems has given rise to a phenomenon known as “patent thickets.” These dense webs of overlapping patent rights can significantly impact innovation, market entry, and competition across various industries and countries.

Licensing 98

Licensing Licensing International Marketing 98

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning if they have their breasts or ovaries.

Research 246

Research 246

Chemical Biology and Drug Design

DECEMBER 11, 2024

The review discusses the systemic development of selective inhibitors for Mtb -DHFR as antitubercular agents and their designing strategies. The study also explores and compiles the latest patents and clinical trial data into a single platform to help develop selective Mtb -DHFR inhibitors for effective tuberculosis treatment. ABSTRACT Tuberculosis (TB) is an obstinate and infectious disease requiring a relatively longer treatment duration than other bacterial infections.

Clinical Trials 100

Clinical Trials Treatment Trials Disease 100

Science Daily: Pharmacology News

DECEMBER 12, 2024

Neanderthal genes make up 1-2% of the genomes of non-Africans. Scientists analyzed the lengths of regions of Neanderthal DNA in 58 ancient Eurasian genomes of early modern humans and determined that the introgressed genes result from interbreeding between Homo sapiens and Neanderthals about 47,000 years ago, over a single, extended period of about 7,000 years.

DNA 300

DNA 300

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. This shift has led to the emergence of integrated contract development and manufacturing organizations (CDMOs), which provide end-to-end support for drug developers.

Drug Development 82

Drug Development Compliance Pharmaceutical Companies Drugs 82

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- Have you been boozing more often than usual? A new blood test might be able to tell if you’re damaging your liver from too many beers, margaritas or belts of scotch, researchers report. A blood-borne byproduct of.

Doctors 246

Doctors Research 246

addgene Blog

DECEMBER 12, 2024

Prime Editing: Precise and Flexible CRISPR Editing Over 75,000 pathogenic genetic variants have been identified in humans and cataloged in the ClinVar database. Previously developed genome editing methods using nucleases and base editors have the potential to correct only a minority of those variants in most cell types. But prime editing, a CRISPR technique developed in David Lius lab in 2019, has added considerably more precision and flexibility to the CRISPR editing world.

DNA 98

DNA 98

Science Daily: Pharmacology News

DECEMBER 12, 2024

A research team has developed an ultra-thin, flexible film that could power next-generation wearable devices using body heat, eliminating the need for batteries.

Research 300

Research 300

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drug Patent Watch

DECEMBER 10, 2024

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines. This article delves into India’s growing importance in generic drug API manufacturing, highlighting the key factors contributing to its success and the challenges it

Government 89

Government Drugs Pharmacy Pharmaceuticals 89

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million adults nationwide showed the obesity rate -- which.

244

244

thought leadership

DECEMBER 9, 2024

In the decades since the FDA first introduced Good Manufacturing Practice (GMP) regulations, the drug and device industry has undergone significant transformation. While the core principles of GMPsafety, efficacy, and qualityremain foundational, the way manufacturers achieve these goals has evolved to keep pace with increasing complexity. Today's manufacturing environment is shaped by the rise of advanced therapies, including biologics, cell and gene therapies , and personalized medicine, each d

Science 75

Science Compliance Regulations FDA 75

Science Daily: Pharmacology News

DECEMBER 11, 2024

A new class of magnetism called altermagnetism has been imaged for the first time in a new study. The findings could lead to the development of new magnetic memory devices with the potential to increase operation speeds of up to a thousand times.

Research 300

Research 300

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

Licensing 82

Licensing Licensing Drugs Pharmaceutical Companies 82

Drug Target Review

DECEMBER 11, 2024

In recent years, regulatory focus has shifted from sensitivity to accuracy, marking a pivotal change in how we approach toxicological assessments. While sensitivity remains essential, our growing understanding of toxicology highlights the critical importance of precise target analysis. This shift in focus is especially critical in toxicology, where accurate target analysis plays a vital role in identifying toxic effects and ensuring patient safety, particularly as the field transitions from trad

International 52

International Laboratories Drugs Pharmacokinetics 52

Reprocell

DECEMBER 11, 2024

Inflammatory bowel disease (IBD) is rising in prevalence across the globe, as the number of individuals diagnosed with the condition has increased by 95% since 1990. 1 Despite the recent scientific advances in therapies for IBD, including ulcerative colitis and Crohns disease, there are still persistent unmet medical needs due to the complexity and chronic nature of these conditions.

Drugs 52

Drugs Disease Drug Development Therapies 52

Science Daily: Pharmacology News

DECEMBER 11, 2024

A new study highlights a hidden challenge of using AI in medical imaging research -- the phenomenon of highly accurate yet potentially misleading results known as 'shortcut learning.' The researchers analyzed thousands of knee X-rays and found that AI models can 'predict' unrelated and implausible traits such as whether patients abstained from eating refried beans or beer.

Research 300

Research 300

Drug Patent Watch

DECEMBER 9, 2024

Biosimilars have faced significant challenges in their analytical characterization. This process involves a comprehensive analysis of the biosimilar’s molecular structure, biological activity, and other quality characteristics to demonstrate similarity to the reference product. The emphasis on analytical and functional testing through sophisticated technology is crucial in overcoming these challenges.

Biosimilars 86

Biosimilars Clinical Trials Immune Response Trials 86

Drugs.com

DECEMBER 13, 2024

FRIDAY, Dec. 13, 2024 -- An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug, imlunestrant, improved progression-free survival in.

Clinical Trials 130

Clinical Trials Drugs Therapies Trials 130

The Premier Consulting Blog

DECEMBER 10, 2024

Bringing a new therapeutic to market is a complex and multifaceted process culminating in submission and approval of a new drug application (NDA). Within the NDA, the chemistry, manufacturing, and controls (CMC) section plays a pivotal role in demonstrating drug quality, safety, and efficacy. In this blog, we demystify the CMC section of NDA preparation , providing insights and guidance for navigating this intricate landscape.

Marketing 52

Marketing Production Compliance Regulations 52

Science Daily: Pharmacology News

DECEMBER 11, 2024

Scientists' findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain.

Vaccine 300

Vaccine 300